10x Genomics, Inc. Share-based Payment Arrangement, Expense
10x Genomics, Inc. (TXG) reported Share-based Payment Arrangement, Expense of $25.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-07
- 10x Genomics, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $25.62M, a 5.98% decline year-over-year.
- 10x Genomics, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $22.64M, a 27.14% decline year-over-year.
- 10x Genomics, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $25.22M, a 22.50% decline year-over-year.
- 10x Genomics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $25.26M, a 25.50% decline year-over-year.
- 10x Genomics, Inc. share-based payment arrangement, expense for fiscal 2025 was $108.80M, a 22.70% decline from fiscal 2024.
- 10x Genomics, Inc. share-based payment arrangement, expense for fiscal 2024 was $140.75M, a 15.69% decline from fiscal 2023.
- 10x Genomics, Inc. share-based payment arrangement, expense for fiscal 2023 was $166.95M, a 22.00% increase from fiscal 2022.
- 10x Genomics, Inc. share-based payment arrangement, expense for fiscal 2022 was $136.85M, a 42.61% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.62M 10-Q · filed 2026-08-07 | $48.26M 10-Q · filed 2026-08-07 | $73.48M derived: sum of 3 quarters · filed 2026-08-07 | $98.74M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $22.64M 10-Q · filed 2026-05-08 | $47.86M derived: sum of 2 quarters · filed 2026-05-08 | $73.13M derived: sum of 3 quarters · filed 2026-05-08 | $100.37M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $25.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $50.48M derived: sum of 2 quarters · filed 2026-02-13 | $77.73M derived: sum of 3 quarters · filed 2026-08-07 | $108.80M 10-K · filed 2026-02-13 |
| 2025-09-30 | $25.26M 10-Q · filed 2025-11-07 | $52.51M derived: sum of 2 quarters · filed 2026-08-07 | $83.58M 10-Q · filed 2025-11-07 | $116.13M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $27.25M 10-Q · filed 2026-08-07 | $58.32M 10-Q · filed 2026-08-07 | $90.86M derived: sum of 3 quarters · filed 2026-08-07 | $124.77M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $31.08M 10-Q · filed 2026-05-08 | $63.62M derived: sum of 2 quarters · filed 2026-05-08 | $97.53M derived: sum of 3 quarters · filed 2026-05-08 | $136.02M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $32.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $66.45M derived: sum of 2 quarters · filed 2026-02-13 | $104.94M derived: sum of 3 quarters · filed 2026-02-13 | $140.75M 10-K · filed 2026-02-13 |
| 2024-09-30 | $33.91M 10-Q · filed 2025-11-07 | $72.40M derived: sum of 2 quarters · filed 2025-11-07 | $108.21M 10-Q · filed 2025-11-07 | $147.45M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $38.49M 10-Q · filed 2025-08-08 | $74.62M 10-Q · filed 2025-08-08 | $113.54M derived: sum of 3 quarters · filed 2026-02-13 | $153.77M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $36.13M 10-Q · filed 2025-05-09 | $75.05M derived: sum of 2 quarters · filed 2026-02-13 | $115.28M derived: sum of 3 quarters · filed 2026-02-13 | $160.98M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $38.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $79.15M derived: sum of 2 quarters · filed 2026-02-13 | $124.85M derived: sum of 3 quarters · filed 2026-02-13 | $166.95M 10-K · filed 2026-02-13 |
| 2023-09-30 | $40.23M 10-Q · filed 2024-10-29 | $85.93M derived: sum of 2 quarters · filed 2024-10-29 | $128.03M 10-Q · filed 2024-10-29 | $169.01M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $45.70M 10-Q · filed 2024-08-08 | $87.80M 10-Q · filed 2024-08-08 | $128.77M derived: sum of 3 quarters · filed 2025-02-13 | $162.28M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $42.10M 10-Q · filed 2024-04-30 | $83.08M derived: sum of 2 quarters · filed 2025-02-13 | $116.59M derived: sum of 3 quarters · filed 2025-02-13 | $152.90M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $40.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $74.49M derived: sum of 2 quarters · filed 2025-02-13 | $110.80M derived: sum of 3 quarters · filed 2025-02-13 | $136.85M 10-K · filed 2025-02-13 |
| 2022-09-30 | $33.51M 10-Q · filed 2023-11-03 | $69.83M derived: sum of 2 quarters · filed 2023-11-03 | $95.87M 10-Q · filed 2023-11-03 | $122.78M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $36.31M 10-Q · filed 2023-08-04 | $62.36M 10-Q · filed 2023-08-04 | $89.26M derived: sum of 3 quarters · filed 2024-02-15 | $115.21M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $26.05M 10-Q · filed 2023-05-04 | $52.95M derived: sum of 2 quarters · filed 2024-02-15 | $78.90M derived: sum of 3 quarters · filed 2024-02-15 | $105.83M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $26.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $52.85M derived: sum of 2 quarters · filed 2024-02-15 | $79.79M derived: sum of 3 quarters · filed 2024-02-15 | $95.96M 10-K · filed 2024-02-15 |
| 2021-09-30 | $25.95M 10-Q · filed 2022-11-03 | $52.88M derived: sum of 2 quarters · filed 2022-11-03 | $69.06M 10-Q · filed 2022-11-03 | $83.33M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $26.93M 10-Q · filed 2022-08-09 | $43.11M 10-Q · filed 2022-08-09 | $57.38M derived: sum of 3 quarters · filed 2023-02-16 | $71.16M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $16.18M 10-Q · filed 2022-05-05 | $30.45M derived: sum of 2 quarters · filed 2023-02-16 | $44.23M derived: sum of 3 quarters · filed 2023-02-16 | $58.08M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $14.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $28.05M derived: sum of 2 quarters · filed 2023-02-16 | $41.91M derived: sum of 3 quarters · filed 2023-02-16 | $48.63M 10-K · filed 2023-02-16 |
| 2020-09-30 | $13.78M 10-Q · filed 2021-11-05 | $27.64M derived: sum of 2 quarters · filed 2021-11-05 | $34.36M 10-Q · filed 2021-11-05 | $39.43M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $13.86M 10-Q · filed 2021-08-06 | $20.57M 10-Q · filed 2021-08-06 | $25.65M derived: sum of 3 quarters · filed 2022-02-18 | $29.52M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $6.72M 10-Q · filed 2021-05-07 | $11.79M derived: sum of 2 quarters · filed 2022-02-18 | $15.67M derived: sum of 3 quarters · filed 2022-02-18 | $18.69M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $8.95M derived: sum of 2 quarters · filed 2022-02-18 | $11.97M derived: sum of 3 quarters · filed 2022-02-18 | $13.33M 10-K · filed 2022-02-18 |
| 2019-09-30 | $3.87M 10-Q · filed 2020-11-12 | $6.90M derived: sum of 2 quarters · filed 2020-11-12 | $8.26M 10-Q · filed 2020-11-12 | $9.32M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $3.02M 10-Q · filed 2020-08-12 | $4.38M 10-Q · filed 2020-08-12 | $5.45M derived: sum of 3 quarters · filed 2021-02-26 | $6.04M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $1.36M 10-Q · filed 2020-05-12 | $2.42M derived: sum of 2 quarters · filed 2021-02-26 | $3.01M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.65M derived: sum of 2 quarters · filed 2021-02-26 | $2.66M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $589.00K 10-Q · filed 2019-11-12 | $1.59M 10-Q · filed 2019-11-12 | ||
| 2017-12-31 | $1.66M 10-K · filed 2020-02-27 |